ClinicalTrials.Veeva

Menu

Tumor Exosome Liquid Biopsy Strategy to Diagnose Pancreatic Cancer

S

Shanghai Jiao Tong University School of Medicine

Status

Invitation-only

Conditions

Pancreatic

Study type

Observational

Funder types

Other

Identifiers

NCT06108531
IIT-2023-0118

Details and patient eligibility

About

This is an observational study of patients diagnosed with pancreatic cancer by pathology, with a control group of patients with pathology suggestive of benign pancreatic lesions and normal subjects, and the diagnostic ability of exosomes to identify patients with pancreatic cancer was assessed through the detection of exosomes in the peripheral blood.

Enrollment

400 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Diagnosis of pancreatic cancer confirmed by imaging (case) Diagnosis of chronic pancreatitis confirmed by imaging (hospital control)

Exclusion criteria

The pathology diagnosis and imaging does not matched Patients with other malignant tumors Patients with other severe systemic diseases

Trial design

400 participants in 2 patient groups

pancreatic patients
Description:
Cases will be the patients with newly-diagnosed pancreatic.
The controls
Description:
Controls will be selected from patients with pancreatitis from the same hospital as the case, matched by gender, race and age (1:1).

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems